Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Hypersensitivities

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Allergic Reactions: Anaphylaxis

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

The Skin Microbiota

The Skin Microbiota

The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...

Acne Infection

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland.

The British journal of dermatology·2020

Same author

Allergic contact dermatitis to nonmethacrylate nail allergens in the UK.

The British journal of dermatology·2020

Same author

(Meth)acrylate allergy: frequently missed?

The British journal of dermatology·2018

Same author

European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013/14.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Same author

Recommendation to test limonene hydroperoxides 0·3% and linalool hydroperoxides 1·0% in the British baseline patch test series.

The British journal of dermatology·2017

Same author

Response to letter to the editor re. Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Search research articles

Video Experimental Relacionado

Updated: Jul 7, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Hidrocortisona: un importante alérgeno cutáneo.

S M Wilkinson¹, P H Cartwright, J S English

¹Department of Dermatology, North Staffordshire Hospital Centre, Stoke-on-Trent, UK.

Lancet (London, England)

|March 30, 1991

Resumen

Un significativo 4,8% de los pacientes con sospecha de dermatitis alérgica de contacto mostraron una alergia a la hidrocortisona. Considere la alergia a la hidrocortisona si las condiciones no mejoran o empeoran después del tratamiento.

Más Videos Relacionados

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Videos de Experimentos Relacionados

Last Updated: Jul 7, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Área de la Ciencia:

Dermatología Dermatología dermatología.
Alergología Alergología.
La medicina clínica es la medicina clínica.

Sus antecedentes:

La dermatitis alérgica de contacto es una afección común de la piel.
La hidrocortisona es un corticosteroide tópico ampliamente utilizado para enfermedades inflamatorias de la piel.

Objetivo del estudio:

Para determinar la incidencia de la alergia a la hidrocortisona en pacientes con sospecha de dermatitis alérgica de contacto.
Para resaltar la importancia de considerar la alergia a la hidrocortisona en los casos de no respuesta o empeoramiento.

Principales métodos:

Población de pacientes: personas con sospecha de dermatitis alérgica de contacto.
Enfoque diagnóstico: evaluación clínica y evaluación de la respuesta a la administración de hidrocortisona.

Principales resultados:

Se identificó una alta incidencia del 4,8% para la alergia a la hidrocortisona.
Esta alergia se observó en pacientes con sospecha de dermatitis alérgica de contacto.

Conclusiones:

La alergia a la hidrocortisona es una preocupación notable en pacientes con sospecha de dermatitis alérgica de contacto.
Los médicos deben considerar la alergia a la hidrocortisona cuando una condición no mejora o se deteriora después del tratamiento con hidrocortisona.